Short-term Follow-Up of 32 Simultaneous Pancreas-Kidney Transplantation

明长生,甑忠广,曾凡军,陈知水,张伟杰,林正斌,魏来,宫念樵,刘斌,蒋继贫,徐逸,陈文伟,陈忠华

DOI: https://doi.org/10.3760/cma.j.issn.0254-1785.2006.01.011

2006-01-01

Abstract:Objective To summarize the short-term results of simultaneous pancreas-kidney transplantation (SPK) at a single-center in China.Methods SPK was performed in 32 consecutive patients from Jan. 2000 to July 2005. All patients had long-standing insulin-dependent diabetes mellitus (IDDM) and subsequent renal failure. Bladder drainage (BD) of exocrine secretion was used in the first 2 cases and enteric drainage (ED) in last 30 patients. The patients were treated with quadruple therapy, which included antilymphocyte globulin (ALG) or anti-CD25 monoclonal antibody induction therapy, prednisone, tacrolimus and mycophenolat-mofetil (MMF).Results SPK was successfully applied to all cases. All patients have achieved excellent renal function and euglycemia, and no further insulin treatment was needed in 8.3± 4.5 days posttransplant. The mean hospital stay was 51.4± 21.3 days. Two patients died due to lung cytomegalovirus infection and secondary sepsis 9 weeks and to acute myocardial infarct 6 months after operation, respectively. The death occurred with func- tioning grafts. Four biopsy-proven renal rejection episodes occurred in 6 to 12 months postoperation. Main complications included wound infections in the side of pancreatic graft, peripancreatitis, and hemorrhage.Conclusion SPK is a effective treatment option for selected patients with type I diabetes mellitus and approaching end-stage renal disease. ED might be a more physiological and prior procedure than BD. The combination of tacrolimus and MMF can be used as a preferred, maintenance immunosuppressive in SPK.